The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton

Abstract Objectives This study aims to investigate the impact of the pro-osteoblastogenic ERK-activated ribosomal S6 kinase (Rsk2) on Tumor necrosis factor (TNF)α-induced bone loss in the craniofacial system, focusing on its role in rheumatoid arthritis (RA). The objective is to understand whether R...

Full description

Saved in:
Bibliographic Details
Main Authors: Gina Marie Georgi, Frédéric Bachmann, Julia Luther, Anja Derer, Patrick Heimel, Stefan Tangl, Bärbel Kahl-Nieke, Aaron LeBlanc, Jill Helms, Georg Schett, Christian Hirsch, Reinhard Gruber, Michael Amling, Thorsten Schinke, Till Koehne, Julian Petersen
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Oral Health
Subjects:
Online Access:https://doi.org/10.1186/s12903-025-05779-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850064799525765120
author Gina Marie Georgi
Frédéric Bachmann
Julia Luther
Anja Derer
Patrick Heimel
Stefan Tangl
Bärbel Kahl-Nieke
Aaron LeBlanc
Jill Helms
Georg Schett
Christian Hirsch
Reinhard Gruber
Michael Amling
Thorsten Schinke
Till Koehne
Julian Petersen
author_facet Gina Marie Georgi
Frédéric Bachmann
Julia Luther
Anja Derer
Patrick Heimel
Stefan Tangl
Bärbel Kahl-Nieke
Aaron LeBlanc
Jill Helms
Georg Schett
Christian Hirsch
Reinhard Gruber
Michael Amling
Thorsten Schinke
Till Koehne
Julian Petersen
author_sort Gina Marie Georgi
collection DOAJ
description Abstract Objectives This study aims to investigate the impact of the pro-osteoblastogenic ERK-activated ribosomal S6 kinase (Rsk2) on Tumor necrosis factor (TNF)α-induced bone loss in the craniofacial system, focusing on its role in rheumatoid arthritis (RA). The objective is to understand whether Rsk2, previously shown to have protective effects in long bones against TNFα-induced bone resorption, exhibits similar effects in the craniofacial region. Materials , and Methods. The study compares mice with TNFα overexpression, Rsk2 knockout mice, and a combination of TNFα, and Rsk2 knockout mice using detailed micro-computed tomography coupled with landmark based morphometric analysis, and classical histology. The overall skull morphology, mandible shape, and the temporomandibular joint were examined. Additionally, histological sections were utilized to examine the synovial membrane. Results Combining TNFα, and Rsk2 deficiency does not further alter overall skull shape compared to TNFα alone. TNFα overexpression shortens the mandibular ramus, exacerbated by Rsk2 absence. Micro-computed tomography (µCT) reveals significant temporomandibular joint damage from TNFα, independent of Rsk2. However, histological sections show increased synovial membrane thickness with TNFα, heightened in the absence of Rsk2. Conclusions Rsk2 mitigates TNFα-induced effects on mandibular ramus length in the craniofacial system but has limited impact on the temporomandibular joint, except for synovial membrane thickness. Overall, Rsk2 demonstrates a weaker preventive effect on TNFα-induced craniofacial bone loss compared to its established role in the appendicular skeleton. Clinical Relevance This study highlights regional differences in Rsk2's protective mechanisms, emphasizing the need for further exploration of the underlying mechanisms for these disparities. Understanding these regional differences can be crucial for the development of targeted therapeutic interventions.
format Article
id doaj-art-2adeaaea09a84d6dac20fdc4e5ef8d13
institution DOAJ
issn 1472-6831
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series BMC Oral Health
spelling doaj-art-2adeaaea09a84d6dac20fdc4e5ef8d132025-08-20T02:49:12ZengBMCBMC Oral Health1472-68312025-03-0125111110.1186/s12903-025-05779-9The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeletonGina Marie Georgi0Frédéric Bachmann1Julia Luther2Anja Derer3Patrick Heimel4Stefan Tangl5Bärbel Kahl-Nieke6Aaron LeBlanc7Jill Helms8Georg Schett9Christian Hirsch10Reinhard Gruber11Michael Amling12Thorsten Schinke13Till Koehne14Julian Petersen15Department of Orthodontics, University of Leipzig Medical Center​Department of Orthodontics, University Medical Center Hamburg-EppendorfInstitute of Osteology, and Biomechanics, University Medical Center Hamburg-EppendorfDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)Department of Oral Surgery, University Clinic of Dentistry, Medical University of ViennaDepartment of Oral Surgery, University Clinic of Dentistry, Medical University of ViennaDepartment of Orthodontics, University Medical Center Hamburg-EppendorfCentre for Oral, Clinical & Translational Sciences, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College LondonDepartment of Surgery, Stanford University School of MedicineDeutsches Zentrum Für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg, and Universitätsklinikum ErlangenClinic of Pediatric and Preventive Dentistry, University of LeipzigDepartment of Oral Biology, University Clinic of Dentistry, Medical University of ViennaInstitute of Osteology, and Biomechanics, University Medical Center Hamburg-EppendorfInstitute of Osteology, and Biomechanics, University Medical Center Hamburg-EppendorfDepartment of Orthodontics, University of Leipzig Medical Center​Department of Orthodontics, University of Leipzig Medical Center​Abstract Objectives This study aims to investigate the impact of the pro-osteoblastogenic ERK-activated ribosomal S6 kinase (Rsk2) on Tumor necrosis factor (TNF)α-induced bone loss in the craniofacial system, focusing on its role in rheumatoid arthritis (RA). The objective is to understand whether Rsk2, previously shown to have protective effects in long bones against TNFα-induced bone resorption, exhibits similar effects in the craniofacial region. Materials , and Methods. The study compares mice with TNFα overexpression, Rsk2 knockout mice, and a combination of TNFα, and Rsk2 knockout mice using detailed micro-computed tomography coupled with landmark based morphometric analysis, and classical histology. The overall skull morphology, mandible shape, and the temporomandibular joint were examined. Additionally, histological sections were utilized to examine the synovial membrane. Results Combining TNFα, and Rsk2 deficiency does not further alter overall skull shape compared to TNFα alone. TNFα overexpression shortens the mandibular ramus, exacerbated by Rsk2 absence. Micro-computed tomography (µCT) reveals significant temporomandibular joint damage from TNFα, independent of Rsk2. However, histological sections show increased synovial membrane thickness with TNFα, heightened in the absence of Rsk2. Conclusions Rsk2 mitigates TNFα-induced effects on mandibular ramus length in the craniofacial system but has limited impact on the temporomandibular joint, except for synovial membrane thickness. Overall, Rsk2 demonstrates a weaker preventive effect on TNFα-induced craniofacial bone loss compared to its established role in the appendicular skeleton. Clinical Relevance This study highlights regional differences in Rsk2's protective mechanisms, emphasizing the need for further exploration of the underlying mechanisms for these disparities. Understanding these regional differences can be crucial for the development of targeted therapeutic interventions.https://doi.org/10.1186/s12903-025-05779-9Geometric morphometricsInflammationRheumatoid arthritisTransgenic mouseTemporomandibular jointsTumor necrosis factor-α, ribosomal s6 kinase 2
spellingShingle Gina Marie Georgi
Frédéric Bachmann
Julia Luther
Anja Derer
Patrick Heimel
Stefan Tangl
Bärbel Kahl-Nieke
Aaron LeBlanc
Jill Helms
Georg Schett
Christian Hirsch
Reinhard Gruber
Michael Amling
Thorsten Schinke
Till Koehne
Julian Petersen
The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
BMC Oral Health
Geometric morphometrics
Inflammation
Rheumatoid arthritis
Transgenic mouse
Temporomandibular joints
Tumor necrosis factor-α, ribosomal s6 kinase 2
title The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
title_full The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
title_fullStr The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
title_full_unstemmed The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
title_short The effect of Rsk2 on TNFα-mediated bone loss in the TMJ and craniofacial skeleton
title_sort effect of rsk2 on tnfα mediated bone loss in the tmj and craniofacial skeleton
topic Geometric morphometrics
Inflammation
Rheumatoid arthritis
Transgenic mouse
Temporomandibular joints
Tumor necrosis factor-α, ribosomal s6 kinase 2
url https://doi.org/10.1186/s12903-025-05779-9
work_keys_str_mv AT ginamariegeorgi theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT fredericbachmann theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT julialuther theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT anjaderer theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT patrickheimel theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT stefantangl theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT barbelkahlnieke theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT aaronleblanc theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT jillhelms theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT georgschett theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT christianhirsch theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT reinhardgruber theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT michaelamling theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT thorstenschinke theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT tillkoehne theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT julianpetersen theeffectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT ginamariegeorgi effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT fredericbachmann effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT julialuther effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT anjaderer effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT patrickheimel effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT stefantangl effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT barbelkahlnieke effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT aaronleblanc effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT jillhelms effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT georgschett effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT christianhirsch effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT reinhardgruber effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT michaelamling effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT thorstenschinke effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT tillkoehne effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton
AT julianpetersen effectofrsk2ontnfamediatedbonelossinthetmjandcraniofacialskeleton